TSE:2397 - DNA Chip Research Inc DNA Chip Research Inc
Sector: Health Care, Industry: Life Sciences Tools & Services
Add to Watchlist
   
Add Alert 


Yahoo Finance
Quarterly TTM
Balance Sheet Cash Flow Income Statement Key Ratios
Adjust Display Metrics

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Graph
Total Assets [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 864.74M
119.2%
743.4M
-14.0%
Total Liabilities [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 95.61M
-3.7%
90.06M
-5.8%
Total Equity [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 769.13M
160.6%
653.33M
-15.1%
Operating CashFlow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -89.52M
-
-259.02M
-
Investing CashFlow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -37.35M
-
-95.17M
-
Financing CashFlow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 564.45M
-
-1.44M
-
Beginning Cash Position [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 220.44M
-37.9%
658.01M
198.5%
End Cash Position [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 658.01M
198.5%
302.38M
-54.0%
Free CashFlow [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -126.89M
-
-312.01M
-
Total Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 360.81M
-0.6%
361.71M
0.3%
Net Income (Cont Operations) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -104.59M
-
-127.8M
-
Diluted Net Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -104.88M
-
-128.09M
-
Diluted EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -23.42
-
-25.17
-
Net Margin [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -29.07%
-
-35.41%
-
Return On Equity [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -19.71%
-
-18.01%
-
Return On Assets [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] -16.66%
-
-15.93%
-
Values are in JPY whenever applicable | Fiscal year ends on March 31
Powered by Morningstar